Table 5.
Multiple logistic regression analysis of baseline fractalkine quartiles in the prediction of MetS and its components at year 2: ORs (n = 390).
| ORs (95% CI) | Q1 | Q2 | Q3 | Q4 | P for trend |
|---|---|---|---|---|---|
| ≤0.28 ng/mL | 0.28–0.43 ng/mL | 0.43–0.64 ng/mL | >0.64 ng/mL | ||
| MetS | |||||
| Model 1 | 1 | 1.61 (0.73–3.52) | 2.81 (1.17–6.74) | 7.05 (2.26–18.00) | <0.001 |
| Model 2 | 1 | 1.64 (0.75–3.63) | 2.89 (1.19–6.98) | 7.18 (2.28–18.59) | <0.001 |
| Model 3 | 1 | 1.80 (0.79–4.10) | 2.67 (1.08–6.59) | 5.31 (1.65–14.09) | 0.016 |
| Model 4 | 1 | 1.81 (0.79–4.16) | 2.65 (1.06–6.61) | 5.17 (1.60–13.74) | 0.019 |
| Model 5 | 1 | 1.67 (0.75–3.73) | 2.86 (1.17–6.99) | 5.73 (1.79–14.34) | 0.007 |
| Model 6 | 1 | 1.50 (0.66–3.40) | 2.64 (1.06–6.56) | 5.94 (1.85–15.09) | 0.006 |
| Central obesity | |||||
| Model 1 | 1 | 1.46 (0.75–2.84) | 2.44 (1.19–4.99) | 5.00 (2.17–11.50) | <0.001 |
| Model 2 | 1 | 1.43 (0.73–2.80) | 2.37 (1.15–4.87) | 4.83 (2.09–11.19) | <0.001 |
| Model 3 | 1 | 1.28 (0.62–2.65) | 1.60 (0.73–3.48) | 2.46 (0.99–6.03) | 0.146 |
| Model 4 | 1 | 1.46 (0.69–3.06) | 1.51 (0.72–2.99) | 2.18 (0.95–6.01) | 0.126 |
| Model 5 | 1 | 1.44 (0.73–2.84) | 2.34 (1.13–4.84) | 4.17 (1.78–9.79) | 0.004 |
| Model 6 | 1 | 1.41 (0.72–2.80) | 2.36 (1.14–4.91) | 4.58 (1.96–10.72) | 0.001 |
| Elevated BP | |||||
| Model 1 | 1 | 0.54 (0.29–1.11) | 1.10 (0.59–2.05) | 1.08 (0.59–2.01) | 0.069 |
| Model 2 | 1 | 0.53 (0.28–1.10) | 1.09 (0.58–2.07) | 1.03 (0.55–1.93) | 0.078 |
| Model 3 | 1 | 0.54 (0.28–1.12) | 1.03 (0.54–1.97) | 0.86 (0.45–1.64) | 0.150 |
| Model 4 | 1 | 0.49 (0.27–1.04) | 0.94 (0.49–1.80) | 0.77 (0.40–1.48) | 0.118 |
| Model 5 | 1 | 0.53 (0.28–1.11) | 1.08 (0.57–2.04) | 0.90 (0.47–1.72) | 0.105 |
| Model 6 | 1 | 0.52 (0.28–1.08) | 1.05 (0.55–1.99) | 0.95 (0.50–1.80) | 0.085 |
| Hyperglycemia | |||||
| Model 1 | 1 | 1.65 (0.82–3.32) | 1.87 (0.92–3.79) | 3.53 (1.60–7.81) | 0.014 |
| Model 2 | 1 | 1.66 (0.82–3.35) | 1.89 (0.93–3.83) | 3.61 (1.63–8.02) | 0.013 |
| Model 3 | 1 | 1.69 (0.83–3.43) | 1.83 (0.90–3.74) | 3.35 (1.49–7.55) | 0.029 |
| Model 4a | 1 | 1.71 (0.84–3.51) | 1.86 (0.90–3.84) | 3.40 (1.49–7.75) | 0.029 |
| Model 5 | 1 | 1.68 (0.83–3.41) | 1.84 (0.90–3.75) | 3.07 (1.24–7.14) | 0.071 |
| Model 6 | 1 | 1.69 (0.83–3.43) | 1.92 (0.94–3.92) | 3.57 (1.60–7.99) | 0.016 |
| Hypertriglyceridemiab | |||||
| Model 1 | 1 | 1.37 (0.71–2.64) | 1.82 (0.93–3.55) | 2.69 (1.33–5.44) | 0.038 |
| Model 2 | 1 | 1.36 (0.70–2.62) | 1.78 (0.91–3.50) | 2.63 (1.30–5.34) | 0.046 |
| Model 3 | 1 | 1.38 (0.71–2.68) | 1.72 (0.87–3.38) | 2.28 (1.01–4.69) | 0.141 |
| Model 4 | 1 | 1.09 (0.55–2.17) | 1.33 (0.65–2.69) | 1.75 (0.83–3.71) | 0.460 |
| Model 5 | 1 | 1.36 (0.70–2.63) | 1.77 (0.90–3.47) | 2.33 (1.03–4.79) | 0.113 |
| Model 6 | 1 | 1.33 (0.67–2.63) | 1.82 (0.91–3.64) | 2.46 (1.19–5.11) | 0.080 |
| Low HDL-cb | |||||
| Model 1 | 1 | 0.84 (0.34–2.10) | 0.93 (0.38–2.32) | 1.51 (0.58–3.98) | 0.595 |
| Model 2 | 1 | 0.86 (0.34–2.15) | 0.96 (0.38–2.38) | 1.59 (0.60–4.24) | 0.550 |
| Model 3 | 1 | 0.86 (0.34–2.16) | 0.95 (0.38–2.38) | 1.50 (0.56–4.05) | 0.665 |
| Model 4 | 1 | 0.92 (0.37–2.34) | 1.04 (0.41–2.64) | 1.69 (0.61–4.63) | 0.603 |
| Model 5 | 1 | 0.85 (0.34–2.14) | 0.96 (0.39–2.40) | 1.64 (0.61–4.42) | 0.532 |
| Model 6 | 1 | 0.92 (0.37–2.34) | 1.05 (0.42–2.64) | 1.78 (0.66–4.80) | 0.502 |
OR: odds ratio, CI: confidence interval.
Model 1: adjusted for age, sex.
Model 2: further adjusted for education attainment, smoking, alcohol, and drinking based on model 1.
Model 3: further adjusted for visceral fat based on model 2.
Model 4: further adjusted for CRP based on model 3.
Model 5: further adjusted for HOMA-IR based on model 2; afor hyperglycemia: further adjusted for FINS based on model 2.
Model 6: further adjusted for TG and HDL-c based on model 2.
bNot adjusted for itself.
Abbreviations as in Table 1.